RPG Active Pharma acquires API business of Raghava Life Sciences for ₹135 crore
The acquisition is a step in RPGAP’s consolidation, based on a buy-and-build strategy to create an API focused organisation
Key takeaways
- Category: Orders & Deals.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.






